Virtu Financial LLC Allogene Therapeutics, Inc. Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$4.92 - $8.21 $66,720 - $111,335	13,561 New	13,561 $67,000
Q3 2022 Nov 07, 2022	BUY	$10.32 - $17.28 $249,000 - $416,931	24,128 New	24,128 $261,000
Q1 2022 May 17, 2022	SELL	$7.65 - $15.29 $272,737 - $545,119	-35,652 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$13.13 - $24.52 $468,110 - $874,187	35,652 New	35,652 $532,000
Q4 2019 Feb 04, 2020	SELL	$24.82 - $31.4 $224,050 - $283,447	-9,027 Closed	0 $0
Q3 2019 Nov 20, 2019	BUY	$26.11 - $32.99 $235,694 - $297,800	9,027 New	9,027 $246,000

162

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.